Lisavanbulin Uses, Dosage, Side Effects and more

Lisavanbulin is under investigation in clinical trial NCT02895360 (Phase 1/2a Study of BAL101553 as 48-hour Infusions in Patients With Advanced Solid Tumors or Recurrent Glioblastoma).

Trade Name Lisavanbulin
Generic Lisavanbulin
Lisavanbulin Other Names Lisavanbulin
Type
Formula C26H29N9O3
Weight Average: 515.578
Monoisotopic: 515.23933583
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.
Share